Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Leases Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Others

GeneDx Holdings (WGS) Minority Interest (2020 - 2021)

GeneDx Holdings has reported Minority Interest over the past 2 years, most recently at $294.7 million for Q1 2021.

Quarterly Minority Interest changed N/A to $294.7 million in Q1 2021 from the year-ago period, while the trailing twelve-month figure was $294.7 million through Mar 2021, changed N/A year-over-year, with the annual reading at $353.2 million for FY2020, N/A changed from the prior year.
Minority Interest was $294.7 million for Q1 2021 at GeneDx Holdings, down from $353.2 million in the prior quarter.
Over five years, Minority Interest peaked at $353.2 million in Q4 2020 and troughed at $294.7 million in Q1 2021.